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Interactions between live Newcastle disease virus (NDV), avian metapneumovirus (aMPV) and infectious bronchitis virus (IBV) vaccines following simultaneous vaccination of day old specific pathogen free (SPF) chicks were evaluated. The chicks were divided into eight groups. One group served as unvaccinated controls, whereas the other seven groups were vaccinated against NDV, aMPV and IBV (single, dual or triple). Haemagglutination inhibition (HI) NDV antibody titres were similar in single, dual or triple-vaccinated groups. Levels of aMPV enzyme-linked immunosorbent assay (ELISA) antibodies were suppressed when the aMPV vaccine was given with other live vaccines. The cellular and local immunity induced by administration of live NDV, aMPV or IBV vaccines (individually or together) showed a significant increase in the expression of CD4+, CD8+ and IgA bearing B-cells in the trachea compared to the unvaccinated group. There were no significant differences between the vaccinated groups. Despite lowering the serological antibody response to aMPV, simultaneous vaccination with live NDV (VG/GA strain), aMPV (subtype B), and IBV (H120) did not affect protection against aMPV or IBV. NDV challenge was not included due to local restrictions; however, HI titres in the NDV vaccinated groups reached above the protective titre. It appears that the efficacy of each of the live vaccines were not compromised when given simultaneously (dual or triple) in young SPF chicks.








Newcastle disease virus (NDV), avian metapneumovirus (aMPV) and infectious bronchitis virus (IBV) are important and common causes of respiratory diseases in chickens. The losses due to these pathogens are significantly reduced by the use of live and inactivated vaccines worldwide, including the use of combined live vaccines.  All three viruses initially replicate in the epithelium of the respiratory tract  ADDIN EN.CITE (; ; ), and their ability to induce protective immunity may therefore be reduced if it is necessary to apply all three live vaccines simultaneously. Previous in vivo studies, demonstrated that IBV interfered with the replication of virulent NDV (), live NDV vaccines () and aMPV vaccines in chickens (). Ganapathy et al. (2005) demonstrated that NDV vaccination delayed the replication of the live aMPV vaccine, and also reduced the humoral antibody responses. These studies relied on serum antibody titres, either measured by ELISA or HI test to demonstrate the impact of simultaneous vaccine application in chicks. Systemic antibody responses have been shown to have a poor correlation with protection against IBV () and aMPV infections (). Working with live NDV+IBV and aMPV vaccine viruses  ADDIN EN.CITE (; ; ), the authors suggested that the protection against these viruses was likely induced by cell-mediated and local immune responses, however this was not investigated.  


















2. Materials and Methods

2.1. Eggs and chicks
Fertile eggs from SPF White Leghorn chickens (Lohmann Animal Health, Cuxhaven, Germany), were incubated and hatched in our facilities (University of Liverpool). Chicks were placed in separate isolation units and maintained according to animal welfare guidelines and under strict biosecurity measures. Food and drinking water were provided ad libitum.
2.2. Vaccines
NDV vaccine (strain VG/GA), aMPV vaccine (subtype B), IBV vaccine (strain H120) were kindly provided by Merial SAS, (Lyon France).Vaccines were reconstituted as recommended by the manufacturer. For NDV and aMPV vaccines, each 1,000 dose vial was reconstituted in 2 ml of chilled sterile water (SW) and thoroughly mixed with 100 ml of SW.  For IBV vaccine, a 5,000 dose vial was reconstituted in 5 ml of SW and then 1 ml was mixed with 100 ml of SW. For dual-vaccination, NDV vaccine was first reconstituted and then followed by aMPV or IBV vials as previously described.  Each pair was then mixed in 100 ml SW. For triple vaccination, NDV, aMPV and IBV were reconstituted as above and all three were diluted in 100 ml of SW.  

2.3. Challenge viruses 

2.3.1. IBV 
The Massachusetts (M41) strain () was grown in embryonated chicken eggs (ECE) and titrated in trachea organ cultures (TOC) as described previously (). Titres were expressed as median ciliostatic doses (CD50) and calculated by the method of (). The titre obtained was 105 CD50/ml.  

2.3.2. aMPV 
 aMPV subtype B () virus  was propagated and titrated in TOC as previously described (). The median ciliostatic  dose was calculated as previously described (). The titre obtained was 104.5 CD50/ml.

3. Experimental designs 
Three hundred and twenty day-old chicks were randomly distributed in eight groups; each group consisted of 40 chicks per isolation unit. The vaccination treatments consisted of either a single NDV, aMPV or IBV vaccine dose, or a combination (dual or triple) of the three (Table 1). Each chick was vaccinated via oculo (50 µl) nasal (50 µl) route. Dosages received by each bird were as recommended by the manufacturers (Table 1). Following vaccination, the chicks were observed daily for clinical signs. Oropharyngeal (OP) swabs were randomly collected prior to vaccination from ten chicks and at 3, 7, 14, 21, 26 and 35 days post vaccination (dpv) from ten chicks per groups for reverse-transcriptase polymerase-chain reaction (RT-PCR) analysis. For serology, blood was collected prior to vaccination and at 21 and 35 dpv from eight chicks in each group. At 21 dpv, five chicks from each group were humanely killed and trachea samples were  collected from each bird, immediately placed in aluminium foil cups containing cryo embedding compound (OCT) and frozen in liquid nitrogen (-190°C). The trachea was used for detection of CD4+, CD8+ and IgA-bearing B cells by immunohistochemistry. All samples were stored at -70oC until processing. At 21 dpv, ten birds from each group were transferred to a different isolation room and one was challenged with 0.1 ml virulent aMPV subtype B (103.5 CD50/bird) by the oculo-nasal route. An additional ten birds from each groups were challenged with 0.1 ml virulent IBV M41 (104 CD50/bird) via the same route. The remaining 15 chickens in each group were left unchallenged. 

3.1. Detection of vaccine viruses by RT-PCR 
Pooled daily swabs were dipped as a single sample per group, per day in a labelled bijou  containing 1.5 ml of guanidium isothiocyanate (solution D) (). RNA was extracted using the guanidinium thiocyanate-phenol chloroform method (). RT-PCR was performed as previously described for NDV (), aMPV () and IBV () . 

3.2. Serology
 NDV antibodies were detected by a haemagglutination inhibition test (HI) (). For aMPV and IBV, sera were tested by commercial enzyme-linked immunosorbent (ELISA) assays (BioChek, Gouda, The Netherlands).

3.3. Immunohistochemical analysis of cell-mediated responses in tracheal sections
Indirect immunohistochemical staining was conducted to quantify immune cell populations of CD4+, CD8+ or IgA-bearing B-cells as previously described  ADDIN EN.CITE (), with some modification. Briefly, tracheal samples were sectioned using a cryostat at 5 μm and mounted on poly-L-lysine-coated glass slides. Sections were immersed in ice-cold acetone for 10 min and air dried at room temperature.
Slides were incubated for 20 min in 0.03% hydrogen peroxide (H2O2) diluted in PBS, and washed three times in PBS. Following incubation with horse serum for 20 min, tissue sections were incubated with specific monoclonal antibodies (Mabs) [Mouse anti-chicken CD4 (Clone CT-4) at 0.5 µg/ml; 1:1000,  mouse anti CD8 alpha (Clone CT‑8) at 0. 25 µg/ml, 1:2000, mouse anti-chicken IgA (Clone A-1) at 0.5 µg/ml, 1:1000]. Slides were incubated overnight at 4ºC. After primary antibody incubation, sections were washed in PBS and incubated with the secondary antibody (anti-mouse IgG) for 30 minutes.  After washing three times with PBS, sections were incubated with 1% Avidin DH and 1% biotinylated horseradish peroxidase (ABC reagent). Colour development was achieved by addition of 4% 3,3-diaminobenzidine (DAB) substrate containing 2% hydrogen peroxide and 2% buffer stock solution. After a further wash in super quality water, tissue sections were counter stained with hematoxylin for one minute. Finally, sections were dehydrated, mounted with aquatic mounting medium and covered with a coverslip. All immunostained CD4+, CD8+ and IgA bearing B-cell cells were counted in five randomly selected microscopic fields (400X magnification). The average number of positive cells per 400X microscopic field was calculated for each cell type and sample.
3.4. Assessment of protection against aMPV challenge
Following aMPV infection, chicks were observed daily up to 13 dpc to record clinical signs. Chicks in each group were examined individually; their beaks were squeezed gently behind the nostrils to show the presence of nasal exudate, and clinical signs were scored as described previously (); No clinical signs = 0, clear nasal exudates = 1, turbid nasal exudates = 2, frothy eyes and/or swollen intraorbital sinuses in conjunction with nasal exudates = 3. Scores for each group were calculated based on the mean observed per total number of chickens at each day. 

3.5. Assessment of protection against IBV challenge
Following IBV M41 challenge, all chicks were observed daily for clinical signs attributable to IBV infection. At 5dpc, the chicks were humanely killed for gross lesions and determine level of protection of the trachea using the ciliostasis test, as previously described (). Ciliary activity was scored as follows; All cilia beating =0, 75% cilia beating =1, 50% cilia beating = 2, 25% cilia beating =3, none beating (100% ciliostasis) = 4. The lower the percentage of ciliary beating (and hence the higher the calculated score), the higher the level of protection afforded by the vaccination.

3.6. Statistical analyses

















4.1. Clinical signs post-vaccination
No clinical signs were observed in any of the vaccinated groups. 

4.2. Detection of vaccine viruses by RT-PCR
 None of the viruses was detected in pooled swabs from any group prior to the vaccination.  NDV was detected at 3 dpv only in the single and dual-vaccinated NDV groups, and up to 7 dpv in the triple vaccinated group (Table 2). aMPV was detected up to 7 dpv in birds that received single vaccine and 14 dpv in those given NDV and aMPV vaccines. In contrast, aMPV was detected for a much longer duration (up to 21 dpv) when administered with IBV or with NDV and IBV vaccines. In all IBV-vaccinated groups, IBV was detected to the end of the experiment. 

4.3. Detection of NDV HI antibodies
HI titres in groups not vaccinated with NDV vaccine remained below the detectable levels. Chicks vaccinated with NDV vaccine either alone or in combination had significantly higher antibody titres than chicks not vaccinated with NDV vaccine (Fig. 1). There were no significant differences in the level of HI antibody titres between groups that received the NDV vaccine. 

4.4. Detection of aMPV antibodies by ELISA 
Sera collected prior to vaccination, or from aMPV unvaccinated groups, did not have detectable levels of aMPV antibodies. At 21 dpv, chickens vaccinated solely with the aMPV vaccine showed significantly higher levels of antibody titre than chickens vaccinated with the aMPV vaccine combined with either NDV and/or IBV (Fig. 2). At 35 dpv, antibody titres in the single aMPV vaccinated chickens remained higher than in the dual or triple vaccinated chickens (Fig. 2). 

4.5. Detection of IBV antibodies by ELISA
No IBV antibodies were detected in sera collected prior to vaccination, or from groups not vaccinated with IBV vaccine. Chicks vaccinated with H120 vaccine alone or in combination with other vaccines showed high level of antibody titre against IBV (Fig. 3). However, there were no significant differences in the level of antibody titres between the groups that received H120 vaccine. 

4.6. CD4+, CD8+ and IgA-bearing B-cells in the trachea
The average counts of CD4+, CD8+ and IgA bearing B-cells in the trachea were evaluated by immunohistochemistry. Single, dual or triple vaccinated groups showed significantly greater expression of CD4+, CD8+ and IgA bearing B-cells (Table 3) in the trachea compared to the unvaccinated control groups. However, there were no significant differences between vaccinated groups at 21 dpv. 

4.7. Effects of NDV and IBV vaccinations on protection against aMPV challenge

4.7.1. Clinical signs 
Following virulent aMPV challenge, no clinical signs were observed in the groups vaccinated with aMPV alone or co-delivered with NDV and/or IBV (Fig. 4). In contrast, chickens not vaccinated against aMPV showed clinical signs, such as clear to turbid nasal discharges at 3 dpc and had completely recovered by 11 dpc. There were no significant differences in clinical signs seen in the groups that did not receive the aMPV vaccine. 

4.8. Effect of NDV and aMPV vaccination on protection against IBV challenge

4.8.1. Clinical signs and gross lesions
Following IBV challenge, no clinical signs were observed in the group vaccinated with H120 vaccine alone or in combination with the other vaccines. Chickens not vaccinated with H120 vaccine showed respiratory clinical signs at 1 dpc which included tracheal râles, coughing, sneezing and head shaking. At necropsy at 5 dpc, chicks vaccinated with H120 vaccine were found to be free of lesions, while unvaccinated chicks had slight congestion in the trachea and pale and mild swelling of the kidneys.   

4.8. 2. TOC assessment for protection against IBV challenge











5. Discussion  

We evaluated the effect of co-delivering live NDV, aMPV and IBV vaccine viruses in combination in SPF chicks. Previous studies have reported the simultaneous application of NDV and aMPV  ADDIN EN.CITE (; ), aMPV and IBV (), or NDV, aMPV and IBV () in chicks. Those studies reported that simultaneous application of live NDV or IBV vaccines reduces humoral antibody responses to virulent aMPV, but the chicks were protected against disease. The authors strongly suggested that cell-mediated immunity may have played an important role in conferring the protection against challenge viruses of NDV, aMPV or IBV but this was not investigated. In the current comprehensive study, in order to generate comparative data, the same strains of live NDV, aMPV and IBV vaccine viruses were given to young SPF chicks in single, dual or triple combinations. In addition to humoral antibody responses, we monitored the cell-mediated and local immune responses in the trachea of the birds using immunohistochemistry.

Following single and simultaneous (dual and triple) application of the live vaccine viruses, to one day old SPF chicks no respiratory or any other clinical signs were found. Similar observations were reported when live NDV and aMPV (), aMPV and IBV () and NDV+IBV and aMPV () were concurrently administered to SPF chicks. In the previous studies  ADDIN EN.CITE (; ; ; ; ; ; ; ), the distribution and persistence of the live vaccine viruses in various tissues and OP swabs were monitored. In our study, we used RT-PCR to trace the vaccine viruses in OP swabs and it was noted that the live IBV vaccine virus was detected throughout the experimental duration.  This demonstrates the persistence of IBV, which also could be related to its ability to dominate the other live respiratory vaccines. Cook et al. (2001) reported that this is likely due the rapid replication of IBV. In our experience, under experimental and field conditions, we are able to detect IBV vaccine viruses by RT-PCR for many weeks following vaccination.

For the NDV vaccine, it appears that the virus is cleared rapidly when given alone or simultaneously with IBV or aMPV, but lasted slightly longer (up to 7 dpv) when all three vaccine viruses were given together. The aMPV vaccine virus could be detected in OP swabs for a much longer (up to 21 dpv) duration when administered with IBV or in combination with IBV and NDV. Prolonged detection of aMPV after dual vaccination with NDV has been reported before (). There appears to be a delayed detection of NDV or aMPV when co-delivered with live IBV vaccine virus, potentially indicating the dominance of IBV virus. Despite this, it is evident that the NDV or IBV vaccine viruses are not completely eliminated, and instead allowed to replicate at a later time when co-administered with IBV.

An important indication of successful vaccine-take is a serological response, as this indicates the ability of the vaccine to attach, replicate and induce immune responses, including humoral antibodies. In this study, IBV and aMPV humoral antibodies were measured using commercial ELISA kits and HI was used for detection of NDV antibodies. For IBV and NDV, the results demonstrate that simultaneous dual or triple vaccinations did not affect the levels of the antibodies induced. This is particularly important for NDV, as HI antibody levels are commonly used as an indicator of protection  ADDIN EN.CITE (; ). For aMPV, the lower humoral antibody titres in groups that were given dual or triple vaccinations were at the same level as previously reported  ADDIN EN.CITE (; ; ).

There are currently no published data on the cell-mediated responses to dual or triple vaccinations, even though such programmes are increasingly practiced in the poultry industry worldwide. We attempted to measure the CD4+ and CD8+ responses in the trachea following single, dual or triple vaccinations. In addition, the trachea was also assessed for IgA-bearing B-cells as an indicator of the local immune response. Responses were evaluated at 21 dpv before the flocks were separated for challenge against IBV or aMPV. Our findings showed significant increases in the expression of CD4+, CD8+ or IgA bearing B-cell in the trachea from vaccinated compared to unvaccinated groups. The absence of significant differences between the vaccinated groups demonstrates that at the tracheal level, similar intensities of cell-mediated responses was induced by the single, dual and triple vaccinations. 
In this study the CD8α was examined thought the other T cell subset might play an important role following the challenge viruses. Following NDV vaccination, it was detected vigorous proliferation in the CD8α and TCRγδ population both in immune and in naïve chickens upon antigen stimulation (Dalgaard eta l., 2010). A previous study investigated lymphocytic responses in the chicken trachea to Mycoplasma gallisepticum infection. By staining for a variety of cell-surface markers (CD4, CD8, TCRγδ, TCRαβ1 and TCRαβ2), the distribution of the different T-cell populations in the tracheal mucosa of infected birds played an important role against the infection (Gaunson et al., 2000). In addition, it demonstrated the importance of γδ T cells, after Salmonella immunization (Berndt,et al., 2006). 

As part of the study, the efficacy of live vaccines when given simultaneously (dual or triple) against single application were compared. For IBV and aMPV, the protections conferred against challenge viruses were evaluated.  For NDV, due to local regulations, no challenge was carried out; instead NDV HI titres following vaccination were used. Our results showed that irrespective of live vaccine combinations, protection against IBV was not affected, as ciliary protection of 95-98% was achieved in all IBV-vaccinated groups. Similar findings have previously been shown in other in vivo studies  ADDIN EN.CITE (; ; ). For NDV, mean HI titres of 2-5 log2 and above were considered to provide clinical protection  ADDIN EN.CITE (; ; ; ; ). In this study, it appears that simultaneous application of live NDV vaccine with aMPV, IBV or both does not compromise the immune response or protection conferred against NDV.  
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Fig.1. NDV HI antibody titres in chickens administered with live NDV vaccine alone or with other live vaccines.  Absent of letters indicate no significant difference between vaccinated groups. Vertical bars represent standard error of the means. n= 8. 

Fig. 2.  aMPV ELISA antibodies in chickens vaccinated with aMPV or with NDV and/or  IBV. Different superscripts represent significant differences in the antibody response. Vertical bars represent standard error of the means (n= 8). 

Fig. 3. IBV ELISA antibodies in chickens vaccinated with IBV alone or with NDV and/or aMPV. Absent of letters indicate no significant difference between vaccinated chickens. Vertical bars represent standard error of the means (n= 8). 

Fig. 4.  Mean clinical scores in the vaccinated and unvaccinated chickens after aMPV challenge. No clinical signs were observed in the chickens vaccinated with aMPV vaccine alone or together with NDV or IBV or both. 


Table 1  
Experimental design for the single and simultaneous application of dual or triple live NDV, aMPV and IBV vaccines in SPF chicks 

Table 2
 RT-PCR detection of vaccine viruses following vaccination of chickens with NDV, aMPV and IBV vaccines

Table 3
 Immunostaining of trachea sections at 21dpv using Mab for presence of CD4+ and CD8+ T-cells and for IgA-bearing B cells 
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